Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

NCT06102057 is registered in ClinicalTrials.gov with TheraOp as lead sponsor.

NCT NCT06102057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06102057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
Lead sponsor
TheraOp
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2024
Completion date
June 30, 2028
Enrollment
110 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced, stage iii non-small cell lung cancer, unresectable